Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Establishing a Surveillance System for Chronic Kidney Disease in the U.S., Program Announcement PEP 2006-R-08, 20402 [E6-5928]
Download as PDF
<![CDATA[
20402
Federal Register / Vol. 71, No. 76 / Thursday, April 20, 2006 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Establishing a
Surveillance System for Chronic
Kidney Disease in the U.S., Program
Announcement PEP 2006–R–08
Correction: This notice was published
in the Federal Register on April 10,
2006, Volume 71, Number 68, page
18102. The matters to be discussed
during the Special Emphasis Panel
meeting have been changed.
Matters to be Discussed: To conduct
an expert review of the scientific and
technical merit of research proposals in
response to the development of a
comprehensive national kidney disease
surveillance system that will capture
and track all manifestations of Chronic
Kidney Disease in the general
population.
FOR FURTHER INFORMATION CONTACT:
Felix Rogers, PhD, M.P.H., Scientific
Review Administrator, CDC, 1600
Clifton Road, NE., Mailstop E–05,
Atlanta, GA 30333, Telephone Number
404.639.6101, e-mail fxr3@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: April 14, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–5928 Filed 4–19–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Exotic Animal Importation, Sale, and
Distribution Discussions; Notice of
Public Meeting
Centers for Disease Control and
Prevention, Department of Health and
Human Services.
ACTION: Notice of public meeting.
hsrobinson on PROD1PC61 with NOTICES
AGENCY:
This notice announces a
public meeting on the subject of the
importation, sale, and distribution of
exotic animals. The purpose of the
SUMMARY:
VerDate Aug<31>2005
14:56 Apr 19, 2006
Jkt 208001
meeting is to gather information and
discuss issues and concerns related to
infectious disease threats associated
with the importation, sale, and
distribution of exotic animals.
DATES: The public meeting will be held
May 18, 2006, from 1 p.m. to 5 p.m. in
Decatur, Georgia. Registration will begin
at 12 p.m.
ADDRESSES: The public meeting will be
held at the following location: Holiday
Inn Decatur Conference Plaza, 130
Clairemont Ave., Decatur, GA 30030.
Persons who are unable to attend the
meeting may e-mail, fax, or mail their
comments to: Attn: Kelly Crossett,
kcrossett@constellagroup.com; fax 919–
544–7507; Constella Group LLC, 2605
Meridian Parkway, Durham, NC 27713;
Written comments regarding the subject
of this meeting that are received by May
18, 2006 will receive the same
consideration as statements made at the
public meeting.
FOR FURTHER INFORMATION CONTACT:
Attn: Kelly Crossett, telephone 919–
313–7615;
kcrossett@constellagroup.com; fax 919–
544–7507; Constella Group LLC, 2605
Meridian Parkway, Durham, NC 27713.
SUPPLEMENTARY INFORMATION:
Participation at the Public Meeting
Submit requests to present a
statement at the public meeting to the
contact listed in the section titled FOR
FURTHER INFORMATION CONTACT. The CDC
should receive your requests to present
oral statements at the public meeting no
later than 10 days prior to the meeting.
Include a written summary of oral
remarks you would like to present and
the estimated time needed for your
presentation. A maximum of 15 minutes
per speaker will be permitted. Requests
received after the date specified above
will be scheduled during the meeting if
time allows; however, the names of
those individuals may not appear on the
written agenda. The CDC will prepare
an agenda of speakers available at the
meeting. To accommodate as many
speakers as possible, the amount of time
allocated to each speaker may be less
than the estimated 15 minute maximum.
Those persons desiring to have
audiovisual equipment available should
notify the CDC when they request
placement on the agenda. All statements
submitted during the meeting will be
considered part of the public record.
Background
Zoonoses are diseases that can be
transmitted from animals to people, and
prevention of zoonoses in humans poses
special challenges and requires
consideration of the role of exotic
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
animals in disease transmission. Wild
exotic animals may carry a variety of
known and emerging zoonotic
pathogens. The 2003 outbreak of
monkeypox in the United States, which
involved 37 confirmed human cases,
ultimately traced back to the
importation of African rodents, and
illustrates the special risk associated
with keeping wild animals as pets.
CDC’s regulations regarding the
importation of African rodents may be
found at 42 CFR 71.56. In addition, CDC
has issued orders prohibiting the
introduction into the United States of
birds from countries where highly
pathogenic avian influenza H5N1
subtype is present and civets. These
actions were taken to prevent the
introduction of monkeypox, avian
influenza, and SARS-coronavirus into
the United States. However, these
actions may not fully protect the general
public against the entry of zoonotic
diseases because they are limited to
specific species.
The American Veterinary Medical
Association (AVMA), the Council of
State and Territorial Epidemiologists
(CSTE), and the National Association of
State Public Health Veterinarians
(NASPHV) have issued position
statements calling for CDC to coordinate
a meeting to address the issue of
infectious disease risks associated with
the importation of exotic animals. This
meeting will invite discussion from
several federal agencies with regulatory
oversight of animals, interested
stakeholders (including AVMA, CSTE,
and NASPHV), and the general public
regarding infectious disease threats
related to exotic animal importation,
sale, and distribution. The public
meeting will be used as a forum to share
information, answer questions, and
discuss potential solutions concerning
infectious disease risks associated with
exotic animal importation, sale, and
distribution.
Public Meeting Procedures
The following procedures for this
meeting are as follows:
1. Admission and participation in the
public meeting are free. The meeting
will be open to all persons who have
requested in advance to present
statements or who register on the day of
the meeting (between 12 p.m. and 1
p.m.).
2. Representatives from the CDC will
conduct the public meeting. A panel of
Federal personnel and representatives
from veterinary and public health
organizations will discuss information
presented by participants.
3. The public meeting is intended as
a forum to share information and
E:\FR\FM\20APN1.SGM
20APN1
]]>Agencies
[Federal Register Volume 71, Number 76 (Thursday, April 20, 2006)]
[Notices]
[Page 20402]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-5928]
[[Page 20402]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel: Establishing a Surveillance System for Chronic Kidney
Disease in the U.S., Program Announcement PEP 2006-R-08
Correction: This notice was published in the Federal Register on
April 10, 2006, Volume 71, Number 68, page 18102. The matters to be
discussed during the Special Emphasis Panel meeting have been changed.
Matters to be Discussed: To conduct an expert review of the
scientific and technical merit of research proposals in response to the
development of a comprehensive national kidney disease surveillance
system that will capture and track all manifestations of Chronic Kidney
Disease in the general population.
FOR FURTHER INFORMATION CONTACT: Felix Rogers, PhD, M.P.H., Scientific
Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop E-05,
Atlanta, GA 30333, Telephone Number 404.639.6101, e-mail fxr3@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: April 14, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-5928 Filed 4-19-06; 8:45 am]
BILLING CODE 4163-18-P
